Skip to Content

Significant Updates on Neoadjuvant Treatments for Stage 3 Melanoma

Marco Donia moderated a press conference on immunotherapy at ESMO 2024. In this MEDtalk, he discusses significant updates on neoadjuvant treatments for stage 3 melanoma, where immunotherapy before surgery improves outcomes, mainly when a significant pathological response is achieved.

Marco Donia

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top